Methods for estimating the case fatality ratio for a novel, emerging infectious disease

American Journal of Epidemiology

Volumn 162, Issue 5, 2005, Pages 479-486

  Ghani, A C ^a,d   Donnelly, C A ^a   Cox, D R ^b   Griffin, J T ^a   Fraser, C ^a   Lam, T H ^c   Ho, L M ^c   Chan, W S ^c   Anderson, R M ^a   Hedley, A J ^c   Leung, G M ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NUFFIELD COLLEGE   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Case fatality ratio; Kaplan Meier estimator; SARS virus; Survival analysis

Indexed keywords

INFECTIOUS DISEASE;

ADULT; AGED; ARTICLE; CHINA; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; DATA ANALYSIS; DEATH; FATALITY; HONG KONG; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MORTALITY; OUTCOMES RESEARCH; PARAMETER; PATIENT; PERFORMANCE; SEVERE ACUTE RESPIRATORY SYNDROME; STATISTICAL MODEL; STATISTICS; SURVIVAL;

COMMUNICABLE DISEASES, EMERGING; FEMALE; HONG KONG; HUMANS; INCIDENCE; MALE; MODELS, STATISTICAL; SEVERE ACUTE RESPIRATORY SYNDROME; SURVIVAL ANALYSIS;

SARS CORONAVIRUS;

EID: 23944439187     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi230     Document Type: Article

References (27)

1. World Health Organization. SARS epidemiology to date. (http://www.who.int/csr/sars/epi2003_04_11/en/). April 11, 2003.
2. Leung GM, Lam TH, Ho LM, et al. The impact of community psychological responses on outbreak control for severe acute respiratory syndrome (SARS) in Hong Kong. J Epidemiol Community Health 2003;57:857-63.
3. Leung GM, Quah S, Ho LM, et al. A tale of two cities: community psychobehavioral surveillance and related impact on outbreak control in Hong Kong and Singapore during the severe acute respiratory syndrome epidemic. Infect Control Hosp Epidemiol 2004;25:1033-41.
4. Fan EX. SARS: economic impacts and implications. (ERD policy brief no. 15). (http://www.adb.org/Documents/EDRC/Policy_Briefs/PB015.pdf). May 2003.
5. World Health Organization. Severe acute respiratory syndrome (SARS). (http://www.who.int/csr/sars/en/). October 2004.
6. Death rate in HK will hit 10 per cent, experts predict. South China Morning Post, April 24, 2003.
7. Mortality rate varies by method of handling data. Asian Wall Street Journal, April 24, 2003.
8. Altman LK. Death rate from virus more than doubles, varying sharply by country. New York Times, April 22, 2003.
9. Cable News Network (CNN). SARS becoming deadlier: officials. (http:/www.cnn.com/2003/HEALTH/04/24/sars.death/). April 25, 2003.
10. Cox DR. The analysis of exponentially distributed lifetimes with two types of failure. J R Stat Soc (B) 1959;21:411-21.
11. Farewell VT. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1982;38:1041-6.
12. Peng Y, Dear KBG, Denham JW. A generalized F mixture model for cure rate estimation. Stat Med 1998;17:813-30.
13. Cox DR, Oakes D. Analysis of survival data. London, United Kingdom: Chapman and Hall/CRC, 1984.
14. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 2003;361:1761-6.
15. Leung GM, Hedley AJ, Ho LM, et al. The epidemiology of severe acute respiratory syndrome (SARS) in the 2003 Hong Kong epidemic: analysis of 1,755 patients. Ann Intern Med 2004;141:662-73.
16. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289:2801-9.
17. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003;58:686-9.
18. Fowler RA, Lapinsky SE, Hallett D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA 2003;290:367-73.
19. Gomersall CD, Joynt GM, Lam P, et al. Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004;30:381-7.
20. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767-72.
21. Wong WW, Chen TL, Yang SP, et al. Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei. J Chin Med Assoc 2003;66:315-17.
22. Leung GM, Chung PH, Tsang T, et al. Seroprevalence of IgG antibody to SARS coronavirus (SARS-CoV) in a population-based sample of close contacts of all 1,755 cases in Hong Kong. Emerg Infect Dis 2004;10:1653-6.
23. Yu WC, Tsang TH, Tong WL, et al. Prevalence of subclinical infection by the SARS coronavirus among general practitioners in Hong Kong. Scand J Infect Dis 2004;36:287-90.
24. Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax 2004;59:252-6.
25. Sung JJ, Wu A, Joynt GM, et al. Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak. Thorax 2004;59:414-20.
26. Tsang K, Seto WH. Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment. Curr Opin Investig Drugs 2004;5:179-85.
27. Zhao Z, Zhang F, Xu M, et al. Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol 2003;52:715-20.